Structural study of Lindqvist polyoxovanadate–peptide conjugates

• DOI: 10.1039/d4nj02851a
• Publication Date: 2025-01-27T08:00:37Z
• Authors: H. Yu; C. Honisch; M. Frigo; N. Balice; S. Mantovani; F. Cammelli; G. Saielli; V. Cocetta; A. Sacilotto; P. Ruzza; M. Carraro

The Lindqvist hexavanadate was functionalized with the antagonist peptide demobesin-1 to evaluate the impact of the polyoxometalate structure on peptide conformation and recognition ability, for a potential anticancer activity.